AAAAAA
Results: 1-25/33
Authors:
Vilenchik, M
Benimetsky, L
Kolbanovsky, A
Miller, P
Stein, CA
Citation: M. Vilenchik et al., Evidence for higher-order structure formation by the c-myb 18-mer phosphorothioate antisense (codons 2-7) oligodeoxynucleotide: Potential relationship to antisense c-myb inhibition, ANTISENSE N, 11(2), 2001, pp. 87-97
Authors:
Stein, CA
Citation: Ca. Stein, Antisense that comes naturally, NAT BIOTECH, 19(8), 2001, pp. 737-738
Authors:
Berton, M
Turelli, P
Trono, D
Stein, CA
Allemann, E
Gurny, R
Citation: M. Berton et al., Inhibition of HIV-1 in cell culture by oligonucleotide-loaded nanoparticles, PHARM RES, 18(8), 2001, pp. 1096-1101
Authors:
Lebedeva, I
Stein, CA
Citation: I. Lebedeva et Ca. Stein, Antisense oligonucleotides: Promise and reality, ANN R PHARM, 41, 2001, pp. 403-419
Authors:
Koehn, RK
Rossi, J
Stein, CA
Citation: Rk. Koehn et al., In defense of antisense, SCIENCE, 293(5532), 2001, pp. 1047-1048
Authors:
Su, ZZ
Lebedeva, IV
Gopalkrishnan, RV
Goldstein, NI
Stein, CA
Reed, JC
Dent, P
Fisher, PB
Citation: Zz. Su et al., A combinatorial approach for selectively inducing programmed cell death inhuman pancreatic cancer cells, P NAS US, 98(18), 2001, pp. 10332-10337
Authors:
Benimetskaya, L
Miller, P
Benimetsky, S
Maciaszek, A
Guga, P
Beaucage, SL
Wilk, A
Grajkowski, A
Halperin, AL
Stein, CA
Citation: L. Benimetskaya et al., Inhibition of potentially anti-apoptotic proteins by antisense protein kinase C-alpha (Isis 3521) and antisense bcl-2 (G3139) phosphorothioate oligodeoxynucleotides: Relationship to the decreased viability of T24 bladder andPC3 prostate cancer cells, MOLEC PHARM, 60(6), 2001, pp. 1296-1307
Authors:
Lebedeva, I
Raffo, A
Rando, R
Ojwang, J
Cossum, P
Stein, CA
Citation: I. Lebedeva et al., Chemosensitization of bladder carcinoma cells by bcl-xL antisense oligonucleotides, J UROL, 166(2), 2001, pp. 461-469
Authors:
Stein, CA
Citation: Ca. Stein, The experimental use of antisense oligonucleotides: a guide for the perplexed, J CLIN INV, 108(5), 2001, pp. 641-644
Authors:
Koziolkiewicz, M
Gendaszewska, E
Maszewska, M
Stein, CA
Stec, WJ
Citation: M. Koziolkiewicz et al., The mononucleotide-dependent, nonantisense mechanism of action of phosphodiester and phosphorothioate oligonucleotides depends upon the activity of an ecto-5 '-nucleotidase, BLOOD, 98(4), 2001, pp. 995-1002
Authors:
Lebedeva, IV
Stein, CA
Citation: Iv. Lebedeva et Ca. Stein, Antisense oligonucleotides in cancer - Recent advances, BIODRUGS, 13(3), 2000, pp. 195-216
Authors:
Stein, CA
Citation: Ca. Stein, Evaluating the mechanism of action of antiproliferative antisense drugs: Aconvergence of views?, ANTISENSE N, 10(2), 2000, pp. 127-127
Authors:
Ma, M
Benimetskaya, L
Lebedeva, I
Dignam, J
Takle, G
Stein, CA
Citation: M. Ma et al., Intracellular mRNA cleavage induced through activation of RNase P by nuclease-resistant external guide sequences, NAT BIOTECH, 18(1), 2000, pp. 58-61
Authors:
Stein, CA
Citation: Ca. Stein, Is irrelevant cleavage the price of antisense efficacy?, PHARM THERA, 85(3), 2000, pp. 231-236
Authors:
Benimetskaya, L
Tonkinson, J
Stein, CA
Citation: L. Benimetskaya et al., Determination of cellular internalization of fluoresceinated oligonucleotides, METH ENZYM, 313, 2000, pp. 287-297
Authors:
Lebedeva, IV
Stein, CA
Citation: Iv. Lebedeva et Ca. Stein, Antisense downregulation of the apoptosis-related Bcl-2 and Bcl-xL proteins: A new approach to cancer therapy, MOL BIOL, 34(6), 2000, pp. 875-887
Authors:
Lebedeva, I
Rando, R
Ojwang, J
Cossum, P
Stein, CA
Citation: I. Lebedeva et al., Bcl-xL in prostate cancer cells: Effects of overexpression and down-regulation on chemosensitivity, CANCER RES, 60(21), 2000, pp. 6052-6060
Authors:
Krieg, AM
Stein, CA
Citation: Am. Krieg et Ca. Stein, Antisense and nucleic acid-based therapeutics: The next millennium, ANTISENSE N, 9(6), 1999, pp. 495-495
Authors:
Simon, AD
Giedd, KN
Schwartz, A
Wang, W
Sun, J
Chen, HJ
Marboe, C
Stein, CA
Rabbani, LE
Citation: Ad. Simon et al., Porous balloon delivery of S-dC28 does not prevent restenosis in the porcine coronary artery model of balloon injury, ANTISENSE N, 9(6), 1999, pp. 549-553
Authors:
Lee, M
Simon, AD
Stein, CA
Rabbani, LE
Citation: M. Lee et al., Antisense strategies to inhibit restenosis, ANTISENSE N, 9(5), 1999, pp. 487-492
Authors:
Lebedeva, IV
Stein, CA
Citation: Iv. Lebedeva et Ca. Stein, Bcl-xL-directed oligonucleotides in prostate and bladder carcinoma cell lines, ANTISENSE N, 9(4), 1999, pp. 381-382
Authors:
Stein, CA
Citation: Ca. Stein, Hybridization prediction gets to first base, NAT BIOTECH, 17(8), 1999, pp. 751-752
Authors:
Stein, CA
Citation: Ca. Stein, Keeping the biotechnology of antisense in context, NAT BIOTECH, 17(3), 1999, pp. 209-209
Authors:
Yamamoto, H
Soh, JW
Monden, T
Klein, MG
Zhang, LM
Shirin, H
Arber, N
Tomita, N
Schieren, I
Stein, CA
Weinstein, IB
Citation: H. Yamamoto et al., Paradoxical increase in retinoblastoma protein in colorectal carcinomas may protect cells from apoptosis, CLIN CANC R, 5(7), 1999, pp. 1805-1815
Authors:
Berton, M
Allemann, E
Stein, CA
Gurny, R
Citation: M. Berton et al., Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complex, EUR J PH SC, 9(2), 1999, pp. 163-170